NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $69.92 +3.30 (+4.95 %) (As of 10/17/2018 02:57 AM ET)Previous Close$66.62Today's Range$66.80 - $70.6952-Week Range$65.67 - $112.25Volume324,000 shsAverage Volume212,017 shsMarket Capitalization$1.77 billionP/E Ratio12.47Dividend YieldN/ABeta0.37 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Magellan Health, Inc. engages in the healthcare management business. It operates through the following segments: Healthcare, Pharmacy Management, and Corporate. The Healthcare segment comprises of the Commercial and Government reporting units. The Pharmacy Management segment offers products and solutions that provide clinical and financial management of pharmaceuticals paid under both the medical and the pharmacy benefit.The Corporate segment covers amounts not allocated to the Healthcare and Pharmacy Management segments. The company was founded in 1969 and is headquartered in Scottsdale, AZ. Receive MGLN News and Ratings via Email Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Hospitals Sub-IndustryManaged Health Care SectorMedical SymbolNASDAQ:MGLN CUSIP55907920 Webwww.magellanhealth.com Phone602-572-6050 Debt Debt-to-Equity Ratio0.56 Current Ratio1.63 Quick Ratio1.58 Price-To-Earnings Trailing P/E Ratio12.47 Forward P/E Ratio15.37 P/E Growth1.58 Sales & Book Value Annual Sales$5.84 billion Price / Sales0.29 Cash Flow$10.2522 per share Price / Cash6.82 Book Value$53.09 per share Price / Book1.32 Profitability EPS (Most Recent Fiscal Year)$5.50 Net Income$110.20 million Net Margins1.66% Return on Equity11.29% Return on Assets4.86% Miscellaneous Employees10,700 Outstanding Shares24,560,000Market Cap$1.77 billion Magellan Health (NASDAQ:MGLN) Frequently Asked Questions What is Magellan Health's stock symbol? Magellan Health trades on the NASDAQ under the ticker symbol "MGLN." How were Magellan Health's earnings last quarter? Magellan Health Inc (NASDAQ:MGLN) released its quarterly earnings data on Friday, July, 27th. The company reported $0.91 earnings per share for the quarter, missing the consensus estimate of $1.06 by $0.15. The business had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.88 billion. Magellan Health had a return on equity of 11.29% and a net margin of 1.66%. Magellan Health's revenue was up 27.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.59 EPS. View Magellan Health's Earnings History. When is Magellan Health's next earnings date? Magellan Health is scheduled to release their next quarterly earnings announcement on Wednesday, November 7th 2018. View Earnings Estimates for Magellan Health. How can I listen to Magellan Health's earnings call? Magellan Health will be holding an earnings conference call on Wednesday, November 7th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8008571812. What guidance has Magellan Health issued on next quarter's earnings? Magellan Health issued an update on its FY18 earnings guidance on Friday, July, 27th. The company provided EPS guidance of $5.18-5.96 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.24. The company issued revenue guidance of $7.3-7.5 billion, compared to the consensus revenue estimate of $7.59 billion. What price target have analysts set for MGLN? 3 brokerages have issued 12-month price objectives for Magellan Health's stock. Their forecasts range from $85.00 to $105.00. On average, they anticipate Magellan Health's stock price to reach $95.00 in the next twelve months. This suggests a possible upside of 35.9% from the stock's current price. View Analyst Price Targets for Magellan Health. What is the consensus analysts' recommendation for Magellan Health? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health. Who are some of Magellan Health's key competitors? Some companies that are related to Magellan Health include MEDNAX (MD), Healthscope (HSO), Select Medical (SEM), Primary Health Care (PRY), Medical Facilities (DR), Capitol Health (CAJ), Animalcare Group (ANCR), SunLink Health Systems (SSY), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC). Who are Magellan Health's key executives? Magellan Health's management team includes the folowing people: Barry M. Smith, Executive Chairman & Chief Executive OfficerJonathan N. Rubin, Chief Financial OfficerSrinivas Koushik, Chief Technology OfficerKaren Amstutz, Chief Medical OfficerJeffrey N. West, Principal Accounting Officer, SVP & Controller Who are Magellan Health's major shareholders? Magellan Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include DNB Asset Management AS (0.18%), Bank of Montreal Can (0.02%) and First Hawaiian Bank (0.02%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Eran Broshy, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health. Which major investors are selling Magellan Health stock? MGLN stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Company insiders that have sold Magellan Health company stock in the last year include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jonathan N Rubin and Mostafa Kamal. View Insider Buying and Selling for Magellan Health. Which major investors are buying Magellan Health stock? MGLN stock was purchased by a variety of institutional investors in the last quarter, including First Hawaiian Bank and DNB Asset Management AS. View Insider Buying and Selling for Magellan Health. How do I buy shares of Magellan Health? Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Magellan Health's stock price today? One share of MGLN stock can currently be purchased for approximately $69.92. How big of a company is Magellan Health? Magellan Health has a market capitalization of $1.77 billion and generates $5.84 billion in revenue each year. The company earns $110.20 million in net income (profit) each year or $5.50 on an earnings per share basis. Magellan Health employs 10,700 workers across the globe. What is Magellan Health's official website? The official website for Magellan Health is http://www.magellanhealth.com. How can I contact Magellan Health? Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected] MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 266 (Vote Outperform)Underperform Votes: 266 (Vote Underperform)Total Votes: 532MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/17/2018 by MarketBeat.com StaffFeatured Article: Stock Selection - What is cash flow?